{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:44:40Z","timestamp":1772034280456,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":6202,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1992,5]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> To review our policy of prophylactic treatment with intravenous immunoglobulin (i.v.IG) in chronic lymphocytic leukemia (CLL), we analyzed the infection history, serum IgG levels (S\u2010IgG) and disease stage of 146 patients who were treated and followed at our institution in 1980\u20131989. S\u2010IgG was available for 98 patients: 55% were hypogammaglobulinemic and 56% had had at least one severe infection. There were significant associations between S\u2010IgG and the occurrence of infections (p&lt;0.01) and disease stage (p &lt; 0.02). There was also a significant association between disease stage and occurrence of infections (p&lt; 0.001). Severe infections tended to accumulate in patients with subnormal S\u2010IgG and advanced disease stage. Totally, 292 infections were recorded, and the incidence of moderate to severe infections was 0.47 per patient year. Infection mortality was high: 42 patients died of a severe infection (46% of all causes of death). Patients with a low S\u2010IgG and advanced disease stage are the most susceptible to death from infection and would be most likely to benefit most from i.v.IG prophylaxis; however, the cost of this therapy is so high that strict individual consideration still remains crucial for treatment decisions.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1992.tb01805.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T11:48:17Z","timestamp":1279453697000},"page":"266-270","source":"Crossref","is-referenced-by-count":67,"title":["Infections and serum IgG levels in patients with chronic lymphocytic leukemia"],"prefix":"10.1111","volume":"48","author":[{"given":"M.","family":"Itala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Helenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nikoskelainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Remes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"291","article-title":"Mechanisms of infection in chronic lymphocytic leukemia","volume":"24","author":"Chapel H.","year":"1987","journal-title":"Semin Hematol"},{"key":"e_1_2_1_3_2","first-page":"249","volume-title":"Chronic lymphocytic leukemia","author":"Bunch C.","year":"1988"},{"key":"e_1_2_1_4_2","first-page":"89","article-title":"Chronic lymphocytic leukemia","author":"Hansen MM.","year":"1973","journal-title":"Scand J Hae-matol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5257.920"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1972.tb03935.x"},{"key":"e_1_2_1_7_2","first-page":"411","volume-title":"Chronic lymphocytic leukemia: Recent Advances, Future Directions","author":"Gale R.","year":"1987"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880115)61:2<279::AID-CNCR2820610215>3.0.CO;2-4"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-197907000-00001"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-51-3-501"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V"},{"key":"e_1_2_1_12_2","volume-title":"Categorical Data Analysis","author":"Agresti A.","year":"1990"},{"key":"e_1_2_1_13_2","volume":"1","author":"Dixon WJ","year":"1990","journal-title":"BMDP Statistical Software Manual"},{"key":"e_1_2_1_14_2","first-page":"1523","article-title":"Elec\u2010trophoretic analysis of serum proteins of the blood dyscra\u2010sias","volume":"33","author":"Brown RK","year":"1948","journal-title":"J Lab Clin Med"},{"issue":"5","key":"e_1_2_1_15_2","first-page":"S87","article-title":"Prophylactic and therapeutic use of immunoglobulin for intravenous administration in patients with secondary immunodeficiencies associated with malignancies","volume":"7","author":"Morell A.","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/blood.V73.2.366.366","article-title":"Crossover study of immunoglobulin replacement therapy in patients with low\u2010grade B\u2010cell tumors","volume":"73","author":"Griffiths H.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1973.03650100076014"},{"key":"e_1_2_1_18_2","first-page":"902","article-title":"Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia","volume":"6","author":"Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia.","year":"1988","journal-title":"New Engl J Med"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1991.tb00532.x"},{"key":"e_1_2_1_20_2","first-page":"470","article-title":"Consensus on IVIG","author":"Editorial","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107113250202"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1992.tb01805.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1992.tb01805.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T17:14:24Z","timestamp":1698081264000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1992.tb01805.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["10.1111\/j.1600-0609.1992.tb01805.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1992.tb01805.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}